Becton Dickinson & Co. | Income Statement

Fiscal year is October-September. All values USD Millions.
2013
2014
2015
2016
2017
2018
Sales/Revenue
8,054
8,446
10,282
12,483
12,093
15,983
Cost of Goods Sold (COGS) incl. D&A
3,884
4,140
5,587
6,492
6,151
8,721
Gross Income
4,170
4,306
4,695
5,991
5,942
7,262
SG&A Expense
2,550
2,616
3,195
3,833
3,699
5,021
EBIT
1,620
1,690
-
2,158
2,243
2,241
Unusual Expense
367
87
475
731
849
774
Non Operating Income/Expense
-
5
71
25
24
339
Interest Expense
133
135
381
407
521
706
Pretax Income
1,165
1,522
739
1,074
976
1,173
Income Tax
236
337
44
98
124
862
Consolidated Net Income
929
1,185
695
976
1,100
311
Net Income
929
1,185
695
976
1,100
311
Net Income After Extraordinaries
565
1,185
695
976
1,100
311
Net Income Available to Common
1,293
1,185
695
976
1,030
159
EPS (Basic)
6.49
5.99
3.35
4.49
4.61
0.60
Basic Shares Outstanding
195
193
203
213
219
258
EPS (Diluted)
6.49
5.99
3.35
4.49
4.61
0.60
Diluted Shares Outstanding
199
198
208
218
224
265
EBITDA
2,079
2,184
2,328
3,208
3,182
4,096
Non-Operating Interest Income
45
59
24
29
79
73
Preferred Dividends
-
-
-
-
70
152

About Becton Dickinson &

View Profile
Address
1 Becton Drive
Franklin Lakes New Jersey 07417
United States
Employees -
Website http://www.bd.com
Updated 07/08/2019
Becton, Dickinson & Co. is a global medical technology company. The company is engaged in the development, manufacture and sale of medical devices, instrument systems and reagents used by healthcare institutions, life science researchers, clinical laboratories, the pharmaceutical industry and the general public. The company operates through two worldwide business segments: BD Medical and BD Life Sciences.